BSG and non-small cell lung carcinoma: Overall, this study revealed the role of CD147-K148me2-driven intercellular crosstalk in the development of immunosuppression in NSCLC and demonstrated that both NSD2 suppression and CD147-K148me2 targeting can be utilized for enhancing the immune response against NSCLC.